Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays
- PMID: 14630517
- PMCID: PMC1241747
- DOI: 10.1289/ehp.6632
Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays
Abstract
A major barrier to understanding the role of polymorphic DNA repair genes for environmental cancer is that the functions of variant genotypes are largely unknown. Using our cytogenetic challenge assays, we conducted an investigation to address the deficiency. Using X-rays or ultraviolet (UV) light, we irradiated blood lymphocytes from 80 nonsmoking donors to challenge the cells to repair the induced DNA damage, and we analyzed expression of chromosome aberrations (CA) specific to the inducing agents. We have genotyped polymorphic DNA repair genes preferentially involved with base excision repair (BER) and nucleotide excision repair (NER) activities (XRCC1, XRCC3, APE1, XPD) corresponding to the repair of X-ray- and UV light-induced DNA damage, respectively. We expected that defects in specific DNA repair pathways due to polymorphisms would cause corresponding increases of specific CA. From our data, XRCC1 399Gln and XRCC3 241Met were associated with significant increases in chromosome deletions compared with the corresponding homozygous wild types (18.27 1.1 vs 14.79 1.2 and 18.22 0.99 vs 14.20 1.39, respectively); XPD 312Asn and XPD 751Gln were associated with significant increases in chromatid breaks compared with wild types (16.09 1.36 vs 11.41 0.98 and 16.87 1.27 vs 10.54 0.87, respectively), p < 0.05. The data indicate that XRCC1 399Gln and XRCC3 241Met are significantly defective in BER, and the XPD 312Asn and XPD 751Gln are significantly defective in NER. In addition, the variant genotypes interact significantly, with limited overlap of the two different repair pathways.
Similar articles
-
Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes.Carcinogenesis. 2002 Feb;23(2):295-9. doi: 10.1093/carcin/23.2.295. Carcinogenesis. 2002. PMID: 11872635
-
Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.BMC Cancer. 2007 Aug 16;7:162. doi: 10.1186/1471-2407-7-162. BMC Cancer. 2007. PMID: 17705814 Free PMC article.
-
XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects.Carcinogenesis. 2001 Sep;22(9):1437-45. doi: 10.1093/carcin/22.9.1437. Carcinogenesis. 2001. PMID: 11532866
-
Use of biomarkers to characterize functions of polymorphic DNA repair genotypes.Int J Hyg Environ Health. 2004 Sep;207(4):301-13. doi: 10.1078/1438-4639-00294. Int J Hyg Environ Health. 2004. PMID: 15471094 Review.
-
Heritable susceptibility factors for the development of cancer.J Radiat Res. 2006;47 Suppl B:B13-7. doi: 10.1269/jrr.47.b13. J Radiat Res. 2006. PMID: 17019047 Review.
Cited by
-
Single nucleotide polymorphism of <italic>GSTP1</italic> and pathological complete response in locally advanced rectal cancer patients treated with neoadjuvant concomitant radiochemotherapy.Radiat Oncol J. 2018 Sep;36(3):218-226. doi: 10.3857/roj.2018.00094. Epub 2018 Sep 30. Radiat Oncol J. 2018. PMID: 30309213 Free PMC article.
-
Human AP endonuclease 1: a potential marker for the prediction of environmental carcinogenesis risk.Oxid Med Cell Longev. 2014;2014:730301. doi: 10.1155/2014/730301. Epub 2014 Aug 26. Oxid Med Cell Longev. 2014. PMID: 25243052 Free PMC article. Review.
-
Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repair systems.Med Oncol. 2017 Apr;34(4):48. doi: 10.1007/s12032-017-0905-6. Epub 2017 Feb 18. Med Oncol. 2017. PMID: 28215024 Review.
-
Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer.Carcinogenesis. 2011 Sep;32(9):1354-60. doi: 10.1093/carcin/bgr117. Epub 2011 Jun 23. Carcinogenesis. 2011. PMID: 21700777 Free PMC article.
-
Clinical outcome of cisplatin-based chemotherapy is associated with the polymorphisms of GSTP1 and XRCC1 in advanced non-small cell lung cancer patients.Clin Transl Oncol. 2015 Sep;17(9):720-6. doi: 10.1007/s12094-015-1299-6. Epub 2015 Jun 2. Clin Transl Oncol. 2015. PMID: 26033426
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous